Brief: Granules Unit Receives FDA Tentative Approval For Generic Amphetamine With 180-Day Exclusivity
08/01/2026 03:03
Jan 8 (Reuters) - Granules India Ltd GRAN.NS: UNIT RECEIVES FDA TENTATIVE APPROVAL FOR GENERIC AMPHETAMINE WITH 180-DAY EXCLUSIVITY Source text: ID:nNSE826LQ6 Further company coverage: GRAN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake